CRT 2026
Spotlight
Dean J. Kereiakes, MD, FACC, MSCAI
Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States
Disclosure(s): Ablative Solutions, Inc.: Stock Options [in privately held companies] (Ongoing); CeleCor Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Egg Medical, Inc: Stock Options [in privately held companies] (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)